SCHEDULE 13G/A: BVCF IV Group Discloses 5.05% Passive Stake in Oculis Holding AG
Beneficial Ownership Statement
BVCF IV, L.P. and its affiliated entities have filed an amended Schedule 13G, confirming a 5.05% passive beneficial ownership stake in Oculis Holding AG.
Summary
- The filing is an Amendment No. 1 to Schedule 13G, indicating an update to a previously disclosed beneficial ownership position.
- The reporting persons are BVCF IV, L.P., BEYEOTECH, BVCF IV GP, Ltd., and Mr. Zhi Yang.
- Collectively, the reporting persons beneficially own 2,191,810 Ordinary Shares of Oculis Holding AG.
- This ownership represents 5.05% of Oculis Holding AG's Ordinary Shares outstanding.
- The percentage is based on 43,367,703 Ordinary Shares issued and outstanding as of November 27, 2024.
- BEYEOTECH directly holds the shares, and is a wholly-owned subsidiary of BVCF IV, L.P.
- BVCF IV GP, Ltd. is the general partner of BVCF IV, L.P., and Mr. Zhi Yang is the sole shareholder and director of BVCF IV GP, Ltd.
- All reporting persons have shared voting and dispositive power over the reported shares.
- The filing was made pursuant to Rule 13d-1(c), indicating a passive investment intent.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership and does not provide specific industry context or trends.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant passive ownership stake in the company, which can influence perceptions of investor confidence and liquidity.
Key Dates
| Date | Description |
|---|---|
| April 28, 2023 | Date of Joint Filing Agreement among the Reporting Persons. |
| November 27, 2024 | Date of event which required the filing of this statement, and the date as of which the number of outstanding shares was determined. |
| February 11, 2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Oculis Holding AG, BVCF IV, BEYEOTECH, BVCF IV GP, Zhi Yang, beneficial ownership, Schedule 13G, passive investment, ordinary shares, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.